• 3m co: Wells Fargo maintains its equalweight recommendation with a price target reduced from USD 115 to USD 93.
  • Amgen inc: Oppenheimer maintains its outperform rating and raises the target price from USD 280 to USD 290.
  • Assura plc: Numis maintains its hold recommendation with a price target reduced from GBX 58 to GBX 50.
  • Aston martin: Kepler Cheuvreux downgrades its recommendation to reduce and lowers the target price from GBX 335 to GBX 200.
  • Bodycote plc: Numis downgrades to hold from add with a price target reduced from GBX 730 to GBX 700.
  • Canadian pacific: Goldman Sachs maintains its buy recommendation with a price target reduced from CAD 119 to CAD 117.
  • Carrier glob: Wells Fargo maintains its equalweight recommendation and reduces the target price from USD 60 to USD 55.
  • Csx corp: Goldman Sachs maintains its buy recommendation and reduces the target price from USD 39 to USD 37.
  • Dover corp: Wells Fargo maintains its equalweight recommendation with a price target reduced from USD 152 to USD 140.
  • Eaton corp: Wells Fargo maintains its equalweight recommendation and reduces the target price from USD 228 to USD 210.
  • Eli lilly: Wells Fargo maintains its overweight rating and raises the target price from USD 615 to USD 650.
  • Emerson elec: Wells Fargo maintains its overweight rating and reduces the target price from USD 110 to USD 105.
  • Ferguson plc: Goldman Sachs maintains its buy recommendation and raises the target price from GBX 14150 to GBX 16050.
  • Fortive corp: Wells Fargo maintains its equalweight recommendation with a price target reduced from USD 79 to USD 75.
  • Games workshop: Goodbody maintains its buy recommendation with a price target raised from GBP 122 to GBP 126.
  • Honeywell int: Wells Fargo maintains its equalweight recommendation with a price target reduced from USD 205 to USD 190.
  • Illinois tool wo: Wells Fargo maintains its equalweight recommendation with a price target reduced from USD 250 to USD 235.
  • Impax asset mana: Singer Capital Markets downgrades to hold from sell with a price target reduced from GBX 645 to GBX 480.
  • Ingersoll-rand: Wells Fargo maintains its overweight rating and reduces the target price from USD 76 to USD 70.
  • Johnson controls: Citi maintains its neutral recommendation with a price target reduced from USD 68 to USD 58.
  • Norfolk southern: Goldman Sachs maintains its buy recommendation with a price target reduced from USD 267 to USD 257.
  • Otis worldwi: Wells Fargo maintains its equalweight recommendation with a price target reduced from USD 92 to USD 82.
  • Parker-Hannifin: Wells Fargo maintains its overweight rating and reduces the target price from USD 465 to USD 425.
  • Pepsico: Wells Fargo maintains its equalweight recommendation with a price target reduced from USD 196 to USD 170.
  • Rhi magnesita: Numis downgrades to hold from reduce with a price target raised from GBX 2500 to GBX 2750.
  • Rockwell automat: Wells Fargo maintains its equalweight recommendation with a price target reduced from USD 317 to USD 291.
  • Royal caribbean: Wells Fargo maintains its overweight recommendation with a price target reduced from USD 127 to USD 123.
  • Charles Schwab: Piper Sandler & Co maintains its overweight recommendation and reduces the target price from USD 86 to USD 75.
  • Stanley black &: Wells Fargo maintains its equalweight recommendation with a price target reduced from USD 102 to USD 82.
  • Tesla: Wells Fargo maintains its equalweight recommendation with a target price reduced from USD 265 to USD 260.
  • Ti fluid systems: Numis downgrades to hold from reduce with a target price raised from GBX 120 to GBX 130.
  • Trane technologi: Wells Fargo maintains its underweight recommendation with a price target reduced from USD 195 to USD 190.
  • Union pac: Goldman Sachs maintains its buy recommendation and reduces the target price from USD 240 to USD 230.
  • Xylem inc: Citi maintains its neutral recommendation with a price target reduced from USD 125 to USD 101.
  • Zscaler: Barclays upgrades to overweight from equalweight with a price target raised from USD 176 to USD 190.